The advantage of reproducibility, higher accuracy, technological advancements, along growth funding by government and venture capitalist investments are likely to boost the growth of intraoperative imaging market. Increase in automated technology benefits physicians, imaging technicians, and patients. However, factors such as stringent regulatory procedures & framework across the globe and enhanced patient safety concerns are the factors expected to restrain the growth of the market. Furthermore, a high excise tax levied on medical devices in the U.S. may also hinder the growth of this market. Increasing collaborations among market players and the design of advanced automation in cancer research for early cancer detection creates growth opportunities in this market.
The market is segmented on the basis of product types, types and geography. On the basis of products, the market is segmented into intraoperative MRI, intraoperative CT, and intraoperative ultrasound. Based on types, this market is segmented into mobile intraoperative CT products, fully intraoperative suites, O-arms, and others. On the basis of geography, the market is segmented into North America, Europe, Asia-Pacific, and Latin America, Middle East & Africa (LAMEA).
Key market players are Medtronics Inc., Siemens Healthcare, Philips Healthcare, Neurologica Corporation, Brainlab AG and Imris Inc.
KEY BENEFITS FOR STAKEHOLDERS:
KEY SEGMENTATION
Key Market Player
Contact us at the Consulting WP office nearest to you or submit a business inquiry online.
Subscribe to Our Newsletter
Published On : December 2019
$ 3600
Published On : December 2019
$ 3600
Published On : December 2019
$ 3600
Published On : December 2019
$ 3600
Published On : December 2019
$ 3600
Published On : December 2019
$ 3600